ADVFN US – Market Content Editor
-
Columbus McKinnon Reports Record Q1 FY27 Orders and Sales, Raises Full-Year Guidance
The industrial technology company posted record orders and revenue following the Kito Crosby acquisition while lifting its fiscal 2027 outlook on stronger demand and integration progress. Key Investor Takeaways Why Columbus McKinnon Stock Is in Focus Columbus McKinnon (NASDAQ:CMCO) reported record first-quarter fiscal 2027 orders and sales while raising its full-year financial outlook, reflecting continued…
-
ICE Reports Strong Second Quarter as Earnings Top Expectations
Intercontinental Exchange Inc. (NYSE:ICE) delivered second-quarter results that exceeded Wall Street’s earnings expectations while matching revenue forecasts, supported by continued growth across each of its three operating divisions. Investors responded positively to the report, with the company’s shares rising about 1.8% in premarket trading on Thursday. Earnings Growth Continues Across the Business ICE reported adjusted…
-
Oracle Shares Climb as Expanded Google Cloud Alliance Brings Gemini AI to Enterprise Software
Oracle (NYSE:ORCL) shares gained 3.3% on Thursday after the company announced a significant expansion of its partnership with Google (NASDAQ:GOOG), bringing Google’s Gemini artificial intelligence models deeper into Oracle’s enterprise software portfolio. The stock also received support from broader gains across the technology sector. The collaboration is designed to give enterprise customers greater flexibility when…
-
Ferrari Raises 2026 Outlook Despite Second-Quarter Earnings Miss
Ferrari N.V. (NYSE:RACE) reported second-quarter results that came in below Wall Street expectations, but investors welcomed the company’s improved full-year outlook, sending the luxury automaker’s shares about 5% higher in premarket trading. The upgraded guidance was supported by continued strength in Ferrari’s personalization business, which helped offset the softer-than-expected quarterly figures. Revenue Grows as Company…
-
Regeneron Beats Second-Quarter Expectations as Dupixent Growth Fuels Strong Results
Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported stronger-than-expected second-quarter results, comfortably surpassing Wall Street forecasts for both earnings and revenue. The company’s performance was driven by continued momentum across its commercial portfolio, led by strong growth in Dupixent, helping lift its shares more than 3% in premarket trading on Thursday. The biotechnology company also updated its full-year…
-
Rocket Lab Wins Three Additional Satellite Launches From iQPS
Rocket Lab Corporation (NASDAQ:RKLB) shares moved higher on Thursday after the space launch company secured a new multi-launch agreement with Japan-based Institute for Q-shu Pioneers of Space, Inc. (iQPS) for three dedicated Electron missions. The announcement expanded the long-running partnership between the two companies and added to Rocket Lab’s growing launch backlog. New Contract Expands…
-
Brunswick Tops Second-Quarter Expectations and Raises Full-Year Guidance
Brunswick Corporation (NYSE:BC) delivered stronger-than-expected second-quarter results, beating Wall Street forecasts for both earnings and revenue as demand remained resilient across its marine recreation businesses. The company also increased its full-year outlook, helping lift its shares modestly in premarket trading on Thursday. The performance was supported by solid OEM demand, continued growth in parts and…
-
Xerox Shares Jump After Earnings Crush Expectations Despite Revenue Miss
Xerox Holdings Corporation (NASDAQ:XRX) posted a strong second-quarter earnings performance that far exceeded Wall Street expectations, although revenue came in slightly below analysts’ forecasts. Investors welcomed the results, sending the company’s shares more than 23% higher in premarket trading on Thursday. The quarter also reflected improving profitability, continued progress integrating Lexmark and further reductions in…
-
Altria Shares Decline After Earnings Miss and Narrowed Full-Year Outlook
Altria Group Inc. (NYSE:MO) shares fell nearly 4% after the tobacco company reported second-quarter earnings that came in slightly below Wall Street expectations, despite revenue exceeding forecasts. The company also narrowed its full-year earnings guidance, with the midpoint of the updated range falling just below analysts’ projections. Management said it continued to make progress on…
-
Bristol Myers Squibb Lifts Full-Year Guidance After Strong Second-Quarter Earnings Beat
Bristol Myers Squibb (NYSE:BMY) reported second-quarter results that comfortably exceeded Wall Street expectations, driven by continued strength across its growth portfolio. The pharmaceutical company also raised its full-year 2026 financial outlook, sending its shares more than 1% higher in premarket trading on Thursday. The stronger-than-expected performance reflected robust sales of several key medicines, helping offset…